Neurosense Therapeutics said it's producing its ALS therapy PrimeC at a commercial scale as it prepares for potential ...

Columnist Dagmar Munn considers when she decided to share the news that she had ALS — and it wasn't when she felt "ready" to ...

The ALS therapy ATLX-1282 was developed with AIchemab's platform, which uses AI to identify therapeutic targets for difficult ...

The nationwide event will cost $20, with all funds benefiting Augie's Quest, which was founded to fund research and raise ALS ...

Implanting a sensor in the brain helped detect intended speech and allowed control of a computer for a man with ALS in a ...

Spinogenix has received clearance from the U.S. Food and Drug Administration (FDA) to launch an expanded access program (EAP) for SPG302, its oral treatment for amyotrophic lateral sclerosis (ALS).

My husband, Todd, and I work New York Times puzzles while we eat breakfast. Because Todd is paralyzed due to ALS, I feed him. We start with the Spelling Bee puzzle, which offers seven letters for you ...

Implanting a sensor in a region of the brain that helps to control speech was shown in a U.S. study to not only decode the intended speech of a man with amyotrophic lateral sclerosis (ALS), but also ...